nicotine has been researched along with 4-hydroxy-2-nonenal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
| Cederbaum, AI; Chen, X; Lu, Y; Wang, K | 1 |
1 review(s) available for nicotine and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |
1 other study(ies) available for nicotine and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.
Topics: Aldehydes; Animals; Aryl Hydrocarbon Hydroxylases; Cell Proliferation; Cotinine; Cyclin-Dependent Kinase Inhibitor p21; Cytochrome P450 Family 2; Disease Models, Animal; Fatty Liver, Alcoholic; Female; Hepatocytes; Liver Regeneration; Mice; Mice, Knockout; Nicotine; Perilipin-2; Reactive Oxygen Species; Signal Transduction; Up-Regulation | 2019 |